InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,713.64
(
0.00%
)
US TECH 100
19,314.80
(
-0.10%
)
Dow Jones
42,025.19
(
0.00%
)
Brent Oil
73.87
(
-0.61%
)
Bitcoin
63,479.02
(
0.84%
)
Post# of 253160
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

lgonber

Send PM Follow Ignore
Followers 12
Posts 648
Boards Moderated 0
Alias Born 12/20/2014

lgonber

Re: None

Friday, 04/28/2017 11:28:57 AM

Friday, April 28, 2017 11:28:57 AM

Post# of 253160
FDA approves RDUS osteoporosis drug
• Radius Health (RDUS +10.5%) heads north on a 4x surge in volume in response to the FDA's approval of TYMLOS (abaloparatide) injection for the treatment of postmenopausal women with osteoporosis at high risk of fracture.
• The company will host a webcast on Monday, May 1, at 7:30 am ET to discuss the approval.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up